 Cue Biopharma, Inc. NASDAQ:CUE Q2 2022 Earnings Conference Call August 23, 2022 4:30 PM ET Company Participants Dan Passeri - Chief Executive Officer Anish Suri - President Chief Scientific Officer Ken Pienta - Acting Chief Medical Officer Matteo Levisetti - SVP, Clinical Development Kerri Millar - Chief Financial Officer Conference Call Participants Stephen Wiley - Stifel Reni Benjamin - JMP Securities Mark Breidenbach - Oppenheimer Operator Greetings and welcome to the Cue Biopharma Update Call. At this time, all participants are in a listen-only mode. 